Study identifies five distinct brain profiles in depression

Magnetoencephalography (MEG) has revealed five distinct neurophysiological profiles among individuals diagnosed with major depressive disorder (MDD), according to a study published in Nature Mental Health. The research, conducted by scientists based in Helsinki, indicates that identical clinical diagnoses can correspond to opposite patterns of brain connectivity. This finding suggests that depression is not a singular biological entity but rather a collection of different physiological states.

MEG reveals neural timing differences

The study utilized MEG to capture millisecond-level data on neural activity, offering a temporal resolution that functional magnetic resonance imaging (fMRI) cannot match. While fMRI tracks slower changes in blood flow, MEG measures the magnetic fields generated directly by electrical activity in the brain. This approach allowed researchers to observe neuronal communication at its actual timescale, providing a more precise view of functional connectivity between brain regions.

Five groups emerge from 263 patients

Analyzing data from 263 people with MDD and 75 healthy controls, the team identified five specific groups based on oscillatory functional connectivity. These clusters differed not only in the strength of connections between brain areas but also in which regions were involved and the frequencies at which these variations occurred. One group exhibited broadly severe symptoms, including high levels of anxiety and rumination alongside reduced daily functioning. Another displayed weaker connectivity and milder symptoms, while a third showed prominent post-traumatic stress features.

A fourth group presented with pronounced depression, substance use issues, and poor overall well-being. The fifth cluster demonstrated the strongest overall connectivity, characterized by significant substance-use symptoms but fewer trauma-related indicators. Satu Palva, director of the Neuroscience Center at the University of Helsinki, noted that in some individuals, functional connectivity was stronger than usual, whereas in others it was weaker.

Implications for treatment variability

This heterogeneity may explain why therapeutic interventions yield inconsistent results across patients. If individuals sharing a diagnosis possess substantially different brain organizations and symptom profiles, averaging them in research studies could obscure meaningful biological distinctions. A therapy targeting one specific pathway might prove effective for one subgroup while failing for another, resulting in modest overall trial outcomes.

Palva cautioned that the field has not yet reached a stage where brain measurements can guide individual treatment choices. However, she described the study as showing one possible route toward personalized care. The authors labeled these findings as "candidate" phenotypes requiring further validation and replication in other samples to determine their stability and clinical utility. Five profiles within this sample do not constitute five new diseases, but they highlight the complexity underlying current diagnostic categories.